John H. Beigel et al. New England Journal of Medicine; May 22nd 2020; doi:10.1056/NEJMoa2007764
Remdesivir was superior to placebo in shortening the time to recovery in adults hospitalized with Covid-19 and evidence of lower respiratory tract infection.
Weblink here